Bain Capital Life Sciences Investors, LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.

Quarter-by-quarter ownership
Bain Capital Life Sciences Investors, LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$17,413,983
-55.1%
8,663,6730.0%1.91%
-38.7%
Q1 2024$38,813,255
+93.1%
8,663,6730.0%3.12%
+61.9%
Q4 2023$20,099,721
+82.7%
8,663,6730.0%1.93%
+56.7%
Q3 2023$11,002,865
-61.4%
8,663,6730.0%1.23%
-58.1%
Q2 2023$28,503,484
+79948.0%
8,663,6730.0%2.94%
-34.0%
Q1 2023$35,608
-29.9%
8,663,6730.0%4.45%
-21.6%
Q4 2022$50,769
-99.9%
8,663,6730.0%5.67%
-18.9%
Q3 2022$58,566,000
+46.3%
8,663,6730.0%6.99%
+48.9%
Q2 2022$40,026,000
+53.8%
8,663,673
+32.8%
4.69%
+85.8%
Q1 2022$26,023,000
-22.3%
6,522,030
+21.1%
2.53%
-4.9%
Q4 2021$33,499,000
-3.9%
5,385,667
+45.7%
2.66%
+22.9%
Q3 2021$34,850,000
-30.6%
3,695,6670.0%2.16%
-34.2%
Q2 2021$50,187,000
-16.1%
3,695,6670.0%3.29%
-2.9%
Q1 2021$59,796,000
-34.8%
3,695,667
+7.3%
3.39%
-41.2%
Q4 2020$91,689,000
+42.9%
3,445,6670.0%5.76%
-3.7%
Q3 2020$64,158,000
-20.4%
3,445,6670.0%5.98%
-29.2%
Q2 2020$80,629,0003,445,6678.44%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 796,458$4,954,0003.22%
Bain Capital Life Sciences Investors, LLC 5,385,667$33,499,0002.66%
Sarissa Capital Management LP 4,299,297$26,742,0002.32%
Avoro Capital Advisors LLC 6,800,000$42,296,0000.72%
Rock Springs Capital Management LP 3,248,950$20,208,0000.47%
Bellevue Group AG 4,164,000$25,900,0000.27%
Orbimed Advisors 2,888,847$17,969,0000.23%
DAFNA Capital Management LLC 140,263$872,0000.22%
Artal Group S.A. 1,200,000$7,464,0000.20%
Bridgefront Capital, LLC 15,622$97,0000.09%
View complete list of MERSANA THERAPEUTICS INC shareholders